Participants who contributed peripheral blood.
datasetposted on 2009-07-07, 01:04 authored by Marc C. Levesque, M. Anthony Moody, Kwan-Ki Hwang, Dawn J. Marshall, John F. Whitesides, Joshua D. Amos, Thaddeus C. Gurley, Sallie Allgood, Benjamin B. Haynes, Nathan A. Vandergrift, Steven Plonk, Daniel C. Parker, Myron S. Cohen, Georgia D. Tomaras, Paul A. Goepfert, George M. Shaw, Jörn E. Schmitz, Joseph J. Eron, Nicholas J. Shaheen, Charles B. Hicks, Hua-Xin Liao, Martin Markowitz, Garnett Kelsoe, David M. Margolis, Barton F. Haynes
There were 14 uninfected control participants who contributed peripheral blood (36% male, mean age 33.5 y [range18–66 y]).a
All participants herein received efavirenz, tenofovir, and emtricitibine daily.b
Viral load comparisons reported as geometric means and were different between on and off ART groups (p = 0.035, t-test).
N/A, not applicable; NR, not reported.